Shell Asset Management CO Ptc Therapeutics, Inc. Transaction History

Shell Asset Management CO

$2.9 Billion
Q2 2025

A detailed history of Shell Asset Management CO transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 1,151 shares of PTCT stock, worth $75,240. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,151

Previous 1,271 9.44%

Holding current value

$75,240

Previous $65,000 13.85%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 23, 2025	SELL	$36.19 - $52.13 $4,342 - $6,255	-120 Reduced 9.44%	1,151 $56,000
Q1 2025 May 14, 2025	SELL	$41.81 - $57.17 $2,174 - $2,972	-52 Reduced 3.93%	1,271 $65,000
Q3 2024 Nov 07, 2024	SELL	$30.39 - $37.66 $2,370 - $2,937	-78 Reduced 5.57%	1,323 $49,000
Q1 2024 Jul 31, 2024	SELL	$24.15 - $31.95 $1,956 - $2,587	-81 Reduced 5.47%	1,401 $43,000
Q4 2023 Feb 14, 2024	SELL	$18.07 - $29.37 $8,041 - $13,069	-445 Reduced 23.09%	1,482 $41,000
Q3 2023 Nov 08, 2023	SELL	$22.41 - $41.99 $649 - $1,217	-29 Reduced 1.48%	1,927 $43,000
Q2 2023 Jul 28, 2023	SELL	$40.4 - $59.1 $444 - $650	-11 Reduced 0.56%	1,956 $80,000
Q1 2023 May 15, 2023	SELL	$38.16 - $48.86 $267 - $342	-7 Reduced 0.35%	1,967 $95,000
Q4 2022 Feb 07, 2023	SELL	$33.53 - $54.79 $11,098 - $18,135	-331 Reduced 14.36%	1,974 $75,000
Q3 2022 Nov 14, 2022	SELL	$41.85 - $53.85 $25,947 - $33,387	-620 Reduced 21.2%	2,305 $116,000
Q2 2022 Aug 09, 2022	BUY	$25.6 - $45.23 $34,867 - $61,603	1,362 Added 87.14%	2,925 $117,000
Q1 2022 May 04, 2022	SELL	$33.33 - $44.6 $7,865 - $10,525	-236 Reduced 13.12%	1,563 $58,000
Q4 2021 Feb 09, 2022	SELL	$35.36 - $41.86 $1,025 - $1,213	-29 Reduced 1.59%	1,799 $72,000
Q3 2021 Nov 04, 2021	SELL	$37.01 - $44.74 $2,590 - $3,131	-70 Reduced 3.69%	1,828 $68,000
Q1 2021 May 10, 2021	SELL	$46.8 - $68.92 $154,627 - $227,711	-3,304 Reduced 63.51%	1,898 $90,000
Q2 2020 Aug 10, 2020	SELL	$42.56 - $54.98 $3,404 - $4,398	-80 Reduced 1.51%	5,202 $264,000
Q1 2020 May 11, 2020	SELL	$32.37 - $59.36 $2,589 - $4,748	-80 Reduced 1.49%	5,282 $236,000
Q4 2019 Feb 13, 2020	SELL	$32.22 - $50.07 $4,446 - $6,909	-138 Reduced 2.51%	5,362 $258,000
Q3 2019 Nov 12, 2019	SELL	$33.82 - $48.17 $1,589 - $2,263	-47 Reduced 0.85%	5,500 $186,000
Q2 2019 Aug 12, 2019	BUY	$35.42 - $45.0 $196,474 - $249,615	5,547 New	5,547 $250,000

Others Institutions Holding PTCT

# of Institutions

308

Shares Held

80.1M

Call Options Held

255K

Put Options Held

151K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $4.68B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Account

Shell Asset Management CO Ptc Therapeutics, Inc. Transaction History